Induced immunity against hepatitis B virus
نویسندگان
چکیده
منابع مشابه
Efficacy of Four Disinfectants Against Hepatitis B Virus
Background and Aim: Hepatitis B virus (HBV) is an important infectious agent in denti-stry necessitating the use of disinfectants to prevent its transmission. This study compared the efficacy of 2/100 sodium hypochlorite disinfectants prepared from 5% solution manufactured by four different manufacturers namely Ashimashi, Paknaz, Vitex and Active for disinfection of surfaces infected with HBV. ...
متن کاملProblems of protection against virus B hepatitis.
Various methods have been employed to reduce hepatitis B infections among patients and staff at high risk. Routine screening tests of all blood donors for hepatitis B surface antigen has reduced post-transfusion hepatitis B. After a control and prevention programme was instituted hepatitis B cross-infection was eliminated from haemodialysis units in Britain. Prophylaxis with specific immunoglob...
متن کاملpost-vaccination immunity against hepatitis b virus and predictors for non-responders among medical staff
background hepatitis b virus (hbv) is a major cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (hcc). hb vaccination is an essential step in the prevention of the disease and its consequent complications. objectives immune status of medical personnel in teaching hospitals of khuzestan is not well known. since these personnel are usually at risk of needle stick and other...
متن کاملPost-vaccination Immunity Against Hepatitis B Virus and Predictors for Non-responders Among Medical Staff
BACKGROUND Hepatitis B virus (HBV) is a major cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC). HB vaccination is an essential step in the prevention of the disease and its consequent complications. OBJECTIVES Immune status of medical personnel in teaching hospitals of Khuzestan is not well known. Since these personnel are usually at risk of needle stick and oth...
متن کاملNovel paradigm for immunotherapy of ovarian cancer by engaging prophylactic immunity against hepatitis B virus
BACKGROUND Only eight women out of one hundred diagnosed with ovarian epithelial cancers, which progressed to the clinical stage IV, survive 10 years. First line therapies: surgery, chemotherapy, and radiation therapy inflict very serious iatrogenic consequences. Passive immunotherapy of ovarian cancers offers only low efficacy. Prophylactic and therapeutic vaccines for ovarian cancers are not ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: World Journal of Hepatology
سال: 2015
ISSN: 1948-5182
DOI: 10.4254/wjh.v7.i12.1660